TokenPost topic

Foghorn Therapeutics

1 TokenPost story is tagged Foghorn Therapeutics. The newest appear first.

Latest Foghorn Therapeutics stories

• Foghorn Therapeutics Posts $0.80 Q3 GAAP EPS, $83.5 Million Revenue

  Research and development expenses fell $1.2 million from a year earlier.

  Nov 10, 2026, 4:05 AM EST · Business